Jazz Pharmaceuti (JAZZ)
$138.51
0.55 (0.40%)
JAZZ Stock Quote Delayed 30 Minutes
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$136.05
Market Cap
8.38B
PE Ratio
16.32
EPS
8.4869
Volume (Avg. Vol.)
995,298
Day's Range
$135.25 - $138.20
52-Week Range
$99.06 - $148.06
Dividend & Yield
N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharmaceuti News
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
Six pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
2 Biotech Stocks to Buy After Earnings
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.
Say Yes to Drugs with a Jazz Pharmaceuticals Credit Spread (JAZZ)
Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last?
5 Pharmaceutical Stocks to Buy Now
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
A Healthy Portfolio Is Heavy in Health Care
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
5 Global Stock Buys and 2 Sells
There a number of outstanding opportunities in European stocks, as long as you can do the work to find them. Here are 5 top performers to start with now.
Decoding the Global Economy
Taking the global market data and decoding it for the average investor. Here are a few things to watch in the weeks and months ahead.
Top 5 Emerging Growth Stocks for February
Investors increasingly focused on fundamentals will be rewarded. You're guaranteed to find strong performances among these five emerging growth buys.
10 Best Stocks Under Barack Obama
The president may not deserve the credit, but these stocks have been the biggest winners under his administration. Here are 10 thriving since he took office.
Where to Invest During the Last Stage of the Market Recovery
Add these stocks from the consumer staples, health care and utilities sectors during this final stage in the U.S. economy's recovery.
Top 5 Emerging Growth Stocks to Buy for January
The list of the top five emerging growth stocks to buy for January include tech and pharmaceutical companies -- as well as a "monster" beverage play.
